A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 2,208 shares of SAGE stock, worth $12,011. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,208
Previous 1,797 22.87%
Holding current value
$12,011
Previous $19,000 21.05%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$7.02 - $13.08 $2,885 - $5,375
411 Added 22.87%
2,208 $15,000
Q2 2024

Jul 30, 2024

SELL
$10.58 - $17.9 $389,037 - $658,200
-36,771 Reduced 95.34%
1,797 $19,000
Q1 2024

May 01, 2024

BUY
$18.62 - $26.95 $31,523 - $45,626
1,693 Added 4.59%
38,568 $722,000
Q4 2023

Jan 24, 2024

SELL
$17.1 - $22.26 $46,306 - $60,280
-2,708 Reduced 6.84%
36,875 $799,000
Q3 2023

Oct 26, 2023

BUY
$16.75 - $48.98 $143,396 - $419,317
8,561 Added 27.6%
39,583 $814,000
Q2 2023

Aug 10, 2023

SELL
$40.65 - $59.54 $67,438 - $98,776
-1,659 Reduced 5.08%
31,022 $1.46 Million
Q1 2023

May 04, 2023

BUY
$37.27 - $46.57 $232,825 - $290,922
6,247 Added 23.63%
32,681 $1.37 Million
Q4 2022

Feb 09, 2023

BUY
$32.2 - $43.61 $740 - $1,003
23 Added 0.09%
26,434 $1.01 Million
Q3 2022

Nov 10, 2022

BUY
$32.28 - $43.27 $322,896 - $432,829
10,003 Added 60.96%
26,411 $1.03 Million
Q2 2022

Jul 26, 2022

BUY
$27.52 - $37.99 $451,548 - $623,339
16,408 New
16,408 $530,000
Q2 2021

Aug 11, 2021

SELL
$54.88 - $79.29 $219,410 - $317,001
-3,998 Closed
0 $0
Q1 2021

May 13, 2021

SELL
$70.65 - $96.76 $57,650 - $78,956
-816 Reduced 16.95%
3,998 $300,000
Q4 2020

Feb 10, 2021

BUY
$58.41 - $89.06 $22,195 - $33,842
380 Added 8.57%
4,814 $417,000
Q3 2020

Nov 12, 2020

BUY
$41.13 - $62.45 $182,370 - $276,903
4,434 New
4,434 $271,000
Q2 2020

Aug 11, 2020

SELL
$25.95 - $43.15 $262,769 - $436,936
-10,126 Closed
0 $0
Q1 2020

May 12, 2020

SELL
$26.15 - $77.24 $77,220 - $228,089
-2,953 Reduced 22.58%
10,126 $291,000
Q4 2019

Feb 12, 2020

BUY
$60.18 - $154.77 $148,945 - $383,055
2,475 Added 23.34%
13,079 $945,000
Q3 2019

Nov 12, 2019

BUY
$140.29 - $189.96 $69,162 - $93,650
493 Added 4.88%
10,604 $1.49 Million
Q2 2019

Aug 13, 2019

BUY
$157.85 - $183.09 $83,186 - $96,488
527 Added 5.5%
10,111 $1.85 Million
Q1 2019

May 13, 2019

BUY
$89.33 - $163.65 $81,111 - $148,594
908 Added 10.47%
9,584 $1.53 Million
Q4 2018

Feb 11, 2019

BUY
$81.94 - $139.71 $19,583 - $33,390
239 Added 2.83%
8,676 $831,000
Q3 2018

Nov 13, 2018

BUY
$138.11 - $169.04 $192,111 - $235,134
1,391 Added 19.74%
8,437 $1.19 Million
Q2 2018

Aug 14, 2018

SELL
$140.36 - $175.76 $3,087 - $3,866
-22 Reduced 0.31%
7,046 $1.1 Million
Q1 2018

May 10, 2018

BUY
$152.15 - $192.33 $170,103 - $215,024
1,118 Added 18.79%
7,068 $1.14 Million
Q4 2017

Feb 12, 2018

BUY
$60.72 - $167.34 $99,459 - $274,102
1,638 Added 37.99%
5,950 $980,000
Q3 2017

Nov 08, 2017

SELL
$61.4 - $88.52 $1.11 Million - $1.59 Million
-18,000 Reduced 80.67%
4,312 $269,000
Q2 2017

Aug 14, 2017

BUY
N/A
22,312
22,312 $1.78 Million

Others Institutions Holding SAGE

About Sage Therapeutics, Inc.


  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $323M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Mirae Asset Global Investments Co., Ltd. Portfolio

Follow Mirae Asset Global Investments Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.